JP2002543825A5 - - Google Patents

Download PDF

Info

Publication number
JP2002543825A5
JP2002543825A5 JP2000618312A JP2000618312A JP2002543825A5 JP 2002543825 A5 JP2002543825 A5 JP 2002543825A5 JP 2000618312 A JP2000618312 A JP 2000618312A JP 2000618312 A JP2000618312 A JP 2000618312A JP 2002543825 A5 JP2002543825 A5 JP 2002543825A5
Authority
JP
Japan
Prior art keywords
protein
pdz
clasp
peptide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000618312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002543825A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/013161 external-priority patent/WO2000069896A2/en
Publication of JP2002543825A publication Critical patent/JP2002543825A/ja
Publication of JP2002543825A5 publication Critical patent/JP2002543825A5/ja
Withdrawn legal-status Critical Current

Links

JP2000618312A 1999-05-14 2000-05-12 造血細胞内分子相互作用 Withdrawn JP2002543825A (ja)

Applications Claiming Priority (27)

Application Number Priority Date Filing Date Title
US13411799P 1999-05-14 1999-05-14
US13411499P 1999-05-14 1999-05-14
US13411899P 1999-05-14 1999-05-14
US60/134,117 1999-05-14
US60/134,114 1999-05-14
US60/134,118 1999-05-14
US16086099P 1999-10-21 1999-10-21
US60/160,860 1999-10-21
US16249899P 1999-10-29 1999-10-29
US60/162,498 1999-10-29
US17045399P 1999-12-13 1999-12-13
US60/170,453 1999-12-13
US17619500P 2000-01-14 2000-01-14
US60/176,195 2000-01-14
US18229600P 2000-02-14 2000-02-14
US60/182,296 2000-02-14
US54727600A 2000-04-11 2000-04-11
US19652800P 2000-04-11 2000-04-11
US19652700P 2000-04-11 2000-04-11
US19626700P 2000-04-11 2000-04-11
US19646000P 2000-04-11 2000-04-11
US60/196,527 2000-04-11
US60/196,528 2000-04-11
US60/196,460 2000-04-11
US09/547,276 2000-04-11
US60/196267 2000-04-11
PCT/US2000/013161 WO2000069896A2 (en) 1999-05-14 2000-05-12 Molecular interactions in haematopoietic cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011029100A Division JP2011102326A (ja) 1999-05-14 2011-02-14 造血細胞内分子相互作用

Publications (2)

Publication Number Publication Date
JP2002543825A JP2002543825A (ja) 2002-12-24
JP2002543825A5 true JP2002543825A5 (cg-RX-API-DMAC7.html) 2007-07-05

Family

ID=27584529

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000618312A Withdrawn JP2002543825A (ja) 1999-05-14 2000-05-12 造血細胞内分子相互作用
JP2011029100A Pending JP2011102326A (ja) 1999-05-14 2011-02-14 造血細胞内分子相互作用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011029100A Pending JP2011102326A (ja) 1999-05-14 2011-02-14 造血細胞内分子相互作用

Country Status (4)

Country Link
EP (1) EP1178817A2 (cg-RX-API-DMAC7.html)
JP (2) JP2002543825A (cg-RX-API-DMAC7.html)
ES (1) ES2436624T3 (cg-RX-API-DMAC7.html)
WO (2) WO2000069896A2 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006717A2 (en) 1998-07-27 2000-02-10 Genentech, Inc. Improved transformation efficiency in phage display through modification of a coat protein
US20030049695A1 (en) * 2001-02-16 2003-03-13 Lu Peter S. PDZ domain interactions and lipid rafts
US6942981B1 (en) 1999-05-14 2005-09-13 Arbor Vita Corporation Method of determining interactions with PDZ-domain polypeptides
US7510824B2 (en) 1999-06-02 2009-03-31 Nono Inc. Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
US7595297B2 (en) * 1999-06-02 2009-09-29 Michael Tymianski Method of reducing injury to mammalian cells
WO2002031512A2 (en) * 2000-10-13 2002-04-18 Arbor Vita Corporation Molecular interactions in hematopoietic cells
JPWO2002088175A1 (ja) * 2001-04-24 2004-08-19 大塚製薬株式会社 クローン病抗体結合性ペプチド及びクローン病の検査方法
AU2011211347B2 (en) * 2001-05-07 2015-02-19 Agriculture Victoria Services Pty Ltd Modification of plant and seed development and plant responses to stresses and stimuli (3)
DE10124342A1 (de) * 2001-05-18 2002-11-28 Biotecon Diagnostics Gmbh Verfahren zum Nachweis von Mikroorganismen der Spezies Yersinia pestis/Yersinia pseudotuberculosis und/oder zur Differzierung zwischen Yersinia pestis und Yersinia pseudotuberculosis
WO2003004604A2 (en) * 2001-07-06 2003-01-16 Genentech, Inc. Phage displayed pdz domain ligands
AU2002321903A1 (en) * 2001-08-03 2003-02-24 Arbor Vita Corporation Molecular interactions in cells
AU2003291558B2 (en) * 2001-08-03 2009-08-13 Arbor Vita Corporation Molecular interactions in neurons
JP2003199459A (ja) 2002-01-07 2003-07-15 Japan Science & Technology Corp リンパ球遊走制御機能欠失モデル非ヒト動物
AU2012202117B2 (en) * 2004-12-21 2014-06-26 Musc Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
EP1827480B1 (en) 2004-12-21 2016-11-09 MUSC Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
US9408381B2 (en) 2004-12-21 2016-08-09 Musc Foundation For Research Development Alpha Connexin c-Terminal (ACT) peptides for use in transplant
RU2418856C2 (ru) * 2005-02-24 2011-05-20 Дзе Скриппс Рисерч Инститьют Изолированные популяции миелоидоподобных клеток костного мозга и способы лечения с ними
US20070014803A1 (en) * 2005-07-01 2007-01-18 Arbor Vita Corporation Methods and compositions for diagnosis and treatment of viral and bacterial infections
CN102408470A (zh) * 2005-12-23 2012-04-11 洛桑大学 用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
JP5296530B2 (ja) * 2006-04-07 2013-09-25 国立大学法人 筑波大学 移植片対宿主病予知マーカーおよびその利用
MX351881B (es) 2012-03-01 2017-11-01 Firststring Res Inc Geles tópicos que contienen péptidos de alfa-conexina c- terminal (act).
WO2016029191A2 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
US20210139932A1 (en) * 2017-05-03 2021-05-13 Biomarin Pharmaceutical Inc. Improved lentiviruses for transduction of hematopoietic stem cells
CN119015448A (zh) 2018-12-20 2024-11-26 芝加哥大学 与用于癌症疗法的治疗肽相关的方法和组合物
EP4199947A4 (en) 2020-08-18 2024-10-16 Onchilles Pharma, Inc. Modified porcine pancreatic elastase proteins
US12138293B2 (en) 2020-10-22 2024-11-12 Xequel Bio, Inc. Peptide formulations and ophthalmic uses thereof
CN114457005B (zh) * 2022-01-12 2024-03-26 佛山市妇幼保健院 一种小儿尿道平滑肌细胞的分离纯化方法
US12667586B2 (en) 2023-03-07 2026-06-30 Glaukos Corporation Treatments for ocular surface disorders
CN120826463A (zh) * 2023-03-31 2025-10-21 杭州启函生物科技有限公司 使用工程化细胞的癌症免疫疗法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof

Similar Documents

Publication Publication Date Title
Marjomäki et al. Internalization of echovirus 1 in caveolae
Lin et al. Kaposi’s sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus
Day et al. Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection
Blanchet et al. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues
Bridge et al. Dynamic organization of splicing factors in adenovirus-infected cells
Guo et al. Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses
Rosa-Calatrava et al. Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization
Spector Nuclear organization of pre-mRNA processing
Tuthill et al. Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles
Kirby et al. Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein
Ferrer et al. Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries
Tong et al. Carboxypeptidase D is an avian hepatitis B virus receptor
Valdivia et al. Fractionation and initial characterization of the kinetochore from mammalian metaphase chromosomes.
Lorenzo et al. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class I major histocompatibility complexes to late endocytic compartments
Baird et al. Arenavirus infection induces discrete cytosolic structures for RNA replication
Young et al. Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350
Omerovic et al. The amino terminus of Epstein-Barr virus glycoprotein gH is important for fusion with epithelial and B cells
Belin et al. Involvement of cellular adhesion sequences in the attachment of adenovirus to the HeLa cell surface
Boyle et al. Association with the cellular export receptor CRM 1 mediates function and intracellular localization of Epstein-Barr virus SM protein, a regulator of gene expression
WO1996026962A1 (en) Mhc-antigen complexes for detecting and purifying antigen-specific t cells
de Haan et al. Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range
JP2011102326A (ja) 造血細胞内分子相互作用
JP2002517245A5 (cg-RX-API-DMAC7.html)
WO2022179349A1 (zh) 新型冠状病毒抗原及其应用
Unchwaniwala et al. Hepatitis B virus polymerase localizes to the mitochondria, and its terminal protein domain contains the mitochondrial targeting signal